Pharmaceutical firms can change trade names

Drugmakers will be allowed to change their initially approved product names (company name plus generic name) to newly or additionally registered trade names prior to launching, the Korea Food and Drug Administration on March 19.

Under the current regulation, pharmaceutical firms with the initially approved trade names are unable to change them due to confusion among customers.

The change...